Yahoo Finance Results
- Thomson Reuters StreetEvents via Yahoo FinanceAug 05 1:29 AM
You will see that Pharma and Food + Beverage segment sales will increase. Now turning to our quarter 2 financial results. As you saw yesterday, we reported strong second quarter operating results.
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) LotionMarket Watch4 days ago
- Peninsula Clarion24 hours ago
- Anchorage Daily News1 day ago
Bausch & Lomb Incorporated company research & investing information. Find executives and the latest company news.
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, believes in equal opportunity for all, without regard to race, religion, color, national origin, citizenship, sex, veteran's status, age, marital status, sexual preference, disability or any other protected personal characteristic.
Find company research, competitor information, contact details & financial data for Bausch & Lomb Incorporated. Get the latest business insights from D&B Hoovers.
Bausch & Lomb Inc. manufactures, markets and/or distributes more than 32 drugs in the U.S.
LAVAL, Quebec, June 12, 2018 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International (NYSE/TSX: VRX), today announced the introduction of Ocuvite® Blue Light eye vitamins, a nutritional supplement formulated with lutein and
Drug information for LUMIFY Redness Reliever Eye Drops by Bausch & Lomb Incorporated. Includes: facts, uses, warnings, directions and more.
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, ...